Pérez-Carrillo JA

Language: Spanish
References: 10
Page: s70-72
PDF size: 180.43 Kb.

REFERENCES

1. Jimenez A, Shaz BH, Bloch EM. Zika virus and the blood supply: what do we Know? Transfus Med Rev. 2017; 31 (1): 1-10. Available in: http://dx.doi.org/10.1016/j.tmrv.2016.08.001

2. Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019; 133 (17): 1854-164.

3. World Health Organization (WHO). WHO Press. One Health – Fact sheet. 2023. p. 1-5.

4. Bhardwaj K. Pathogen reduction technology. Transfusion Update. 2015; 11: 242-242.

5. Bloch EM, Goel R, Wendel S, Burnouf T, Al-Riyami AZ, Ang AL et al. Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries. Vox Sang. 2021; 116 (1): 18-35. Available in: https://onlinelibrary.wiley.com/doi/abs/10.1111/vox.12970

6. Gamba MR, LeBlanc TT, Vazquez D, Pereira dos Santos E Franco OH. Capacidad de preparación y respuesta de América Latina y el Caribe frente a emergencias sanitarias. Rev Panam Salud Publica. 2022; 46: e99. Disponible en: https://doi.org/10.26633/RPSP.2022.99

7. Red Cross Red. Climate Center. In the Americas, surging dengue fever linked to climate change. 2025. p. 1-3.

8. Omidkhoda A, Razi B, Arabkhazaeli A, Amini Kafi-Abad S. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety. BMC Infect Dis. 2020; 20 (1): 736.

9. Candotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion-transmission risk. Transfus Clin Biol. 2017; 24 (3): 189-195.

10. Allain JP, Goodrich R. Pathogen reduction of whole blood: utility and feasibility. Transfus Med. 2017; 27 Suppl 5: 320-326. Available in: https://onlinelibrary.wiley.com/doi/10.1111/tme.12456